G1 Therapeutics, Inc. (GTHX)
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Address
700 PARK OFFICES DRIVE
RESEARCH TRIANGLE PARK, NC 27709
Founded
2008
Number of Employees
100
Website
http://www.g1therapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at GTHX make a trade.
Creating a free account takes less than one minute